STERIS plc (NYSE:STE) Shares Acquired by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd lifted its position in shares of STERIS plc (NYSE:STE) by 63.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 7,120 shares of the medical equipment provider’s stock after buying an additional 2,763 shares during the period. Y Intercept Hong Kong Ltd’s holdings in STERIS were worth $1,464,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in STE. Mirae Asset Global Investments Co. Ltd. increased its holdings in STERIS by 25.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,387 shares of the medical equipment provider’s stock valued at $2,005,000 after purchasing an additional 1,713 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in STERIS by 32.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 7,705 shares of the medical equipment provider’s stock valued at $1,869,000 after purchasing an additional 1,904 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in STERIS by 6.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 11,455 shares of the medical equipment provider’s stock valued at $2,778,000 after purchasing an additional 735 shares in the last quarter. Autumn Glory Partners LLC acquired a new stake in STERIS in the 3rd quarter valued at $337,000. Finally, Strategic Wealth Investment Group LLC increased its holdings in STERIS by 6.3% in the 3rd quarter. Strategic Wealth Investment Group LLC now owns 4,667 shares of the medical equipment provider’s stock valued at $1,100,000 after purchasing an additional 275 shares in the last quarter. 94.69% of the stock is currently owned by institutional investors and hedge funds.

STERIS Stock Performance

NYSE:STE opened at $223.83 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 1-year low of $197.82 and a 1-year high of $248.24. The firm has a 50-day moving average of $213.84 and a two-hundred day moving average of $223.22. The stock has a market cap of $21.99 billion, a P/E ratio of 47.52 and a beta of 0.84.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. On average, research analysts expect that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Stockholders of record on Thursday, February 20th will be given a dividend of $0.57 per share. The ex-dividend date of this dividend is Thursday, February 20th. This represents a $2.28 annualized dividend and a dividend yield of 1.02%. STERIS’s payout ratio is 48.41%.

Analyst Ratings Changes

Several brokerages recently issued reports on STE. JMP Securities reiterated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research report on Friday, November 8th. StockNews.com cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, October 29th. Stephens reissued an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. Finally, Piper Sandler upped their price objective on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a research report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, STERIS has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.